Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
|
|
16.
|
|
|
17.
|
|
|
18.
|
The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial. [electronic resource] by
- Stefanutti, C
- Blom, D J
- Averna, M R
- Meagher, E A
- Theron, H dT
- Marais, A D
- Hegele, R A
- Sirtori, C R
- Shah, P K
- Gaudet, D
- Vigna, G B
- Sachais, B S
- Di Giacomo, S
- du Plessis, A M E
- Bloedon, L T
- Balser, J
- Rader, D J
- Cuchel, M
Producer: 20160303
In:
Atherosclerosis vol. 240
Availability: No items available.
|